TRCT
ELAT

Tower Research Capital (TRC)’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Tower Research Capital (TRC)’s Portfolio ELAT Stock Details ELAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-505
Closed -$10K – 6720
2022
Q4 		$10K Buy
505
+463
+1,102% +$9.31K ﹤0.01% 4138
2022
Q3 		$1K Sell
42
-808
-95% -$23.1K ﹤0.01% 5953
2022
Q2 		$27K Sell
850
-3,248
-79% -$122K ﹤0.01% 3495
2022
Q1 		$167K Buy
4,098
+2,523
+160% +$106K ﹤0.01% 1859
2021
Q4 		$70K Buy
1,575
+678
+76% +$32.6K ﹤0.01% 2496
2021
Q3 		$45K Buy
+897
New +$46.7K ﹤0.01% 3055
2021
Q2 		– Sell
-17
Closed -$1K – 6065
2021
Q1 		$1K Sell
17
-83
-83% -$3.98K ﹤0.01% 5265
2020
Q4 		$5K Sell
100
-5,507
-98% -$263K ﹤0.01% 4666
2020
Q3 		$249K Buy
5,607
+3,372
+151% +$142K ﹤0.01% 2360
2020
Q2 		$86K Sell
2,235
-1,326
-37% -$53.6K ﹤0.01% 2606
2020
Q1 		$146K Buy
+3,561
New +$171K 0.01% 871

Tower Research Capital (TRC)'s ELAT Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 505 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in ELAT in Q1 2020 and held it in 11 quarters. The position peaked at $249K in Q3 2020. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 505 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $10K.
  • Tower Research Capital (TRC) first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $249K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.